The connection made in this study between CD patients having both chronic MAP bacteremia and IL-17 immunoreactivity and some of the similarities in cytokine expression in CD and Tuberculosis reinforces the proposed role of MAP in the pathophysiology of CD. The gene discussed is IL17A; the disease is bacterial infectious disease with sepsis.